Preventive effect of immunosuppressive agents against indomethacin-induced small intestinal ulcers in rats
- 1 April 1994
- journal article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 39 (4) , 787-795
- https://doi.org/10.1007/bf02087425
Abstract
The mechanism of nonsteroidal antiinflammatory drug-induced intestinal ulcers is not clearly understood. To evaluate whether immunosuppressants have a preventive effect against indomethacin-induced gastrointestinal damage, we investigated the effects of prednisolone, cyclosporin, and the newly developed immunosuppressant FK-506 in intracolonically indomethacin-treated rats: 24 mg/kg of indomethacin, administered intracolonically for two days, caused gastric ulcers and two types of small intestinal ulcers (longitudinal ulcers and scattered small ulcers). Pretreatment with intraperitoneal immunosuppressants reduced the size of gastric ulcers. Both cyclosporin (10 mg/kg) and FK-506 (1 mg/kg, 2 mg/kg) treatments significantly reduced the incidence and the length of the longitudinal ulcers of the small intestine when compared to the vehicle-treated controls, whereas prednisolone (20 mg/kg) did not show any preventive effect. Furthermore, the number of small scattered ulcers of the small intestine was significantly reduced by the high dose of FK-506 (2 mg/kg), but not by cyclosporin or prednisolone. These findings indicate that immunosuppressants have protective and antiinflammatory effects in indomethacin-induced gastroenteropathy, suggesting that cytokines may be important mediators in the pathogenesis of enteropathy induced by nonsteroidal antiinflammatory drugs.Keywords
This publication has 31 references indexed in Scilit:
- Effects of cyclosporin A and FK506 on ischemia/reperfusion-induced neutrophil infiltration in the catDigestive Diseases and Sciences, 1991
- The Role of Ciclosporin Therapy in Crohn’s DiseaseDigestive Diseases, 1991
- Experimental non-steroidal anti-inflammatory drug-induced enteropathy in the rat: similarities to inflammatory bowel disease and effect of thromboxane synthetase inhibitors.Gut, 1990
- EFFECT OF A NEW IMMUNOSUPPRESSIVE AGENT, FK506, ON HUMAN LYMPHOCYTE RESPONSES IN VITROTransplantation, 1989
- Platelet-activating factor and cellular immune responsesImmunology Today, 1987
- Oxygen free radicals interact with indomethacin to cause gastrointestinal injuryInflammation Research, 1986
- T-cell abnormalities in inflammatory bowel disease are mediated by interleukin 2Clinical Immunology and Immunopathology, 1984
- Prostaglandin E inhibits the production of human interleukin 2.The Journal of Experimental Medicine, 1982
- Ulcerative enterocolitis in dogs induced by drugsThe Journal of Pathology, 1980
- Indomethacin-induced intestinal inflammationDigestive Diseases and Sciences, 1977